Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/10797
Title: | Prognostic value of 18F-FDG PET/CT in patients with malignant pleural mesothelioma. | Austin Authors: | Lee, S T;Ghanem, M;Herbertson, R A;Berlangieri, Salvatore U ;Byrne, Amanda J;Tabone, K;Mitchell, Paul L R ;Knight, Simon R ;Feigen, Malcolm;Scott, Andrew M | Affiliation: | Centre for PET, Austin Health, Heidelberg, Victoria, Australia | Issue Date: | 28-Mar-2009 | Publication information: | Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging 2009; 11(6): 473-9 | Abstract: | To evaluate prognostic value of integrated 2-deoxy-2-[F-18]fluoro-D: -glucose-positron emission tomography/computed tomography (FDG-PET/CT) and correlate histopathological subtype with maximum standardized uptake value (SUV(max)) and survival in patients with malignant mesothelioma (MM).Retrospective review of FDG-PET/CT scans, with derivation of SUV(max) of FDG-avid lesions, was performed in patients with biopsy-proven MM. Clinical follow-up and Kaplan-Meier survival analysis was performed.Forty-six patients (37 M:9 F; mean age 61 years) with MM had a FDG-PET/CT scan in a 30-month period. Follow-up was available on 44/46 (96%) patients. Metastatic disease was detected in 9/46 (20%) patients on FDG-PET/CT, where 8/9 were previously undetected. Better survival was found in patients without metastases (p value < 0.05). Mean SUV(max) of primary pleural lesions in patients with metastatic disease was significantly higher than in patients without metastatic disease (p value < 0.05). Progression-free survival was significantly better in the epithelioid histology group compared to the biphasic group (p value 0.015).Detection of extrathoracic metastases on FDG-PET/CT and nonepithelioid histopathology are poor prognostic indicators in patients with MM. | Gov't Doc #: | 19330385 | URI: | https://ahro.austin.org.au/austinjspui/handle/1/10797 | DOI: | 10.1007/s11307-009-0203-6 | Journal: | Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging | URL: | https://pubmed.ncbi.nlm.nih.gov/19330385 | Type: | Journal Article | Subjects: | Adult Aged Aged, 80 and over Australia Disease-Free Survival Female Fluorodeoxyglucose F18.diagnostic use.metabolism Follow-Up Studies Humans Kaplan-Meier Estimate Male Mesothelioma.pathology.radiography.radionuclide imaging Middle Aged Pleural Neoplasms.pathology.radiography.radionuclide imaging Positron-Emission Tomography.methods Prognosis Radiopharmaceuticals.diagnostic use.metabolism Time Factors Tomography, Emission-Computed.methods |
Appears in Collections: | Journal articles |
Files in This Item:
File | Size | Format | |
---|---|---|---|
19330385.pdf | 55.68 kB | Adobe PDF | View/Open |
Page view(s)
52
checked on Nov 2, 2024
Download(s)
124
checked on Nov 2, 2024
Google ScholarTM
Check
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.